OBJECTIVES: To assess the use of traditional and robotic assisted laparoscopy by Society of Gynecologic Oncology (SGO) members and to compare the results with those of our published survey in 2004. METHODS: Surveys were mailed to SGO members, and anonymous responses were collected by mail or through a web site. Data were analyzed and compared with those of our previous survey. In addition, we gathered information on the effect of robotic assisted surgery on the management of gynecologic malignancies. RESULTS: Three hundred eighty-eight (46%) of 850 SGO members responded to the survey. Three hundred fifty-two (91%) indicated that they performed laparoscopic surgery in their practice (compared with 84% in the 2004 survey). The three most common laparoscopic procedures were laparoscopic hysterectomy and staging for uterine cancer (43%), diagnostic laparoscopy for adnexal masses (39%), and prophylactic bilateral oophorectomy for high-risk women (11%). Although 76% of respondents had received either limited or no laparoscopic training during their fellowship, 78% now believe that maximum or much emphasis should be placed on laparoscopic training (55% in the 2004 survey). Twenty-four percent of respondents indicated that they performed robotic assisted surgery, with 66% indicating that they planned to increase their use of the procedure in the next year. CONCLUSIONS: We found an overall increase in the use of and perceived indications for minimally invasive surgery in gynecologic oncology among SGO members. Endometrial cancer staging has become an accepted indication for laparoscopy. In addition, most respondents were planning on increasing their use of robotic assisted surgery in the next year.
OBJECTIVES: To assess the use of traditional and robotic assisted laparoscopy by Society of Gynecologic Oncology (SGO) members and to compare the results with those of our published survey in 2004. METHODS: Surveys were mailed to SGO members, and anonymous responses were collected by mail or through a web site. Data were analyzed and compared with those of our previous survey. In addition, we gathered information on the effect of robotic assisted surgery on the management of gynecologic malignancies. RESULTS: Three hundred eighty-eight (46%) of 850 SGO members responded to the survey. Three hundred fifty-two (91%) indicated that they performed laparoscopic surgery in their practice (compared with 84% in the 2004 survey). The three most common laparoscopic procedures were laparoscopic hysterectomy and staging for uterine cancer (43%), diagnostic laparoscopy for adnexal masses (39%), and prophylactic bilateral oophorectomy for high-risk women (11%). Although 76% of respondents had received either limited or no laparoscopic training during their fellowship, 78% now believe that maximum or much emphasis should be placed on laparoscopic training (55% in the 2004 survey). Twenty-four percent of respondents indicated that they performed robotic assisted surgery, with 66% indicating that they planned to increase their use of the procedure in the next year. CONCLUSIONS: We found an overall increase in the use of and perceived indications for minimally invasive surgery in gynecologic oncology among SGO members. Endometrial cancer staging has become an accepted indication for laparoscopy. In addition, most respondents were planning on increasing their use of robotic assisted surgery in the next year.
Authors: Richard R Barakat; Gali Lev; Amanda J Hummer; Yukio Sonoda; Dennis S Chi; Kaled M Alektiar; Nadeem R Abu-Rustum Journal: Gynecol Oncol Date: 2007-01-02 Impact factor: 5.482
Authors: Antonio Gil-Moreno; Oriol Puig; María A Pérez-Benavente; Berta Díaz; Ramona Vergés; Javier De la Torre; José M Martínez-Palones; Jordi Xercavins Journal: J Minim Invasive Gynecol Date: 2005 Mar-Apr Impact factor: 4.137
Authors: Michael Frumovitz; Ricardo dos Reis; Charlotte C Sun; Michael R Milam; Michael W Bevers; Jubilee Brown; Brian M Slomovitz; Pedro T Ramirez Journal: Obstet Gynecol Date: 2007-07 Impact factor: 7.661
Authors: Rohit Tejwani; Brian J Young; Hsin-Hsiao S Wang; Steven Wolf; J Todd Purves; John S Wiener; Jonathan C Routh Journal: J Pediatr Urol Date: 2017-02-22 Impact factor: 1.830
Authors: Lesley B Conrad; Pedro T Ramirez; William Burke; R Wendel Naumann; Kari L Ring; Mark F Munsell; Michael Frumovitz Journal: Int J Gynecol Cancer Date: 2015-07 Impact factor: 3.437
Authors: Pamela T Soliman; Michael Frumovitz; Whitney Spannuth; Marilyn J Greer; Sheena Sharma; Kathleen M Schmeler; Pedro T Ramirez; Charles F Levenback; Lois M Ramondetta Journal: Gynecol Oncol Date: 2010-08-12 Impact factor: 5.482
Authors: Pamela T Soliman; Michael Frumovitz; Charlotte C Sun; Ricardo Dos Reis; Kathleen M Schmeler; Alpa M Nick; Shannon N Westin; Jubilee Brown; Charles F Levenback; Pedro T Ramirez Journal: Gynecol Oncol Date: 2011-08-27 Impact factor: 5.482